Tablet-based screening improves continence management in multiple sclerosis

Heidi N Beadnall, Kushi E Kuppanda, Annmaree O'Connell, Todd A Hardy, Stephen W Reddel, Michael H Barnett, Heidi N Beadnall, Kushi E Kuppanda, Annmaree O'Connell, Todd A Hardy, Stephen W Reddel, Michael H Barnett

Abstract

Objective: To investigate whether electronic continence questionnaires aid early identification and optimizes management of sphincter dysfunction in a multiple sclerosis clinic.

Methods: A custom designed, tablet-based cross-platform software tool was designed to capture validated multiple sclerosis (MS) patient-reported outcomes. An unselected cohort of MS patients from a tertiary referral clinic completed electronic tablet-based versions of the Bladder Control Scale (BLCS) and the Bowel Control Scale in the waiting room. Data were captured wirelessly "on-the-fly" and stored in a deidentified, secure database; and individual questionnaire results were immediately available to the treating neurologist in the electronic medical record. Scores of ≥2 on either questionnaire generated an automated electronic referral to the clinic MS continence nurse (MS CN).

Results: One hundred and fifty-seven MS patients completed a total of 184 electronic continence test sets and on two occasions only the BLCS was completed. An automatic electronic referral for formal continence review was generated 128 times in 108 patients. Fifty-seven formal continence assessments were undertaken by the MS CN following automated referral. All reviews resulted in at least one clinical intervention being made.

Interpretation: Tablet-based data capture and automated continence referral using this software tool is an efficient, sensitive, and feasible method of screening MS patients for bladder and bowel dysfunction. Concordance with the results of formal continence assessment in this pilot study validates the use of this technology as a screening tool.

Figures

Figure 1
Figure 1
Automated electronic referral received by the multiple sclerosis continence nurse.
Figure 2
Figure 2
Web-based form completed by the multiple sclerosis continence nurse.
Figure 3
Figure 3
Patients with MS complete electronic questionnaires on the iPad® and the information is automatically captured in real time on a secure server. Deidentified data are stored on-the-fly in an aggregated research database. Individual results are linked in the patient’s electronic medical record. If patients reach threshold scores on continence questionnaires, an automated referral to the MS CN is generated. Questionnaire results and information from formal continence assessment are used to guide individual patient management. MS, multiple sclerosis; CN, continence nurse.

References

    1. Ziemssen T. Symptom management in patients with multiple sclerosis. J Neurol Sci. 2011;311:S48–S52.
    1. Gallien P, Gich J, Sánchez-Dalmau BF, Feneberg W. Multidisciplinary management of multiple sclerosis symptoms. Eur Neurol. 2014;72(suppl 1):20–25.
    1. Saguil A, Kane S, Farnell E. Multiple sclerosis: a primary care perspective. Am Fam Physician. 2014;90:644–652.
    1. DasGupta R, Fowler CJ. Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies. Drugs. 2003;63:153–166.
    1. Nortvedt MW, Riise T, Fruga J, et al. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler. 2007;13:106–112.
    1. Wollin J, Bennie M, Leech C, et al. Multiple sclerosis and continence issues: an exploratory study. Br J Nurs. 2005;14:439–446.
    1. Koch T, Kralik D, Eastwood S, et al. Breaking the silence: women living with multiple sclerosis and urinary incontinence. Int J Nurs Pract. 2001;7:16–23.
    1. Koch T, Kralik D, Kelly S. We just don’t talk about it: men living with urinary incontinence and multiple sclerosis. Int J Nurs Pract. 2000;6:253–260.
    1. Buckley B. It‘s the way you ask that matters: comparison of data relating to prevalence of incontinence aid use from two surveys of people with multiple sclerosis. J Wound Ostomy Continence Nurs. 2006;33:26–29.
    1. Enck P, Bielefeldt K, Wolfgang R, et al. Epidemiology of faecal incontinence in selected patient groups. Int J Colorectal Dis. 1991;6:143–146.
    1. Denys P, Phe V, Even A, Chartier-Kastler E. Therapeutic strategies of urinary disorders in MS: practice and algorithms. Ann Phys Rehabil Med. 2014;57:297–301.
    1. Burks J, Chancellor M, Bates D, et al. Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients. Int J MS Care. 2013;15:182–192.
    1. Mahajan ST, Patel PB, Marrie RA. Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry. J Urol. 2010;183:1432–1437.
    1. De Sèze M, Ruffion A, Denys P, et al. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler. 2007;13:915–928.
    1. Ritvo P, Fischer J, Miller D, et al. Multiple sclerosis quality of life inventory: a user’s manual. New York, United States of America: National Multiple Sclerosis Society; 1997. pp. 1–35.
    1. Williams D. Management of bladder dysfunction in patients with multiple sclerosis. Nurs Stand. 2012;26:39–46.
    1. Fowler CJ, Panicker JN, Drake M, et al. A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009;80:470–477.
    1. Hennessey A, Robertson NP, Swingler R, Compston DAS. Urinary, faecal and sexual dysfunction in patients with multiple sclerosis. J Neurol. 1999;246:1027–1032.
    1. Hinds JP, Wald A. Colonic and anorectal dysfunction associated with multiple sclerosis. Am J Gastroenterol. 1989;84:587–595.
    1. Koch T, Kelly S. Identifying strategies for managing urinary incontinence with women who have multiple sclerosis. J Clin Nurs. 1999;8:550–559.
    1. Hemmett L, Holmes J, Barnes M, Russell N. What drives quality of life in multiple sclerosis? QJM. 2004;97:671–676.
    1. Nortvedt MW, Riise T, Myhr K-M, et al. Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler. 2001;7:231–235.
    1. Khan F, Pallant JF, Shea TL, Whishaw M. Multiple sclerosis: prevalence and factors impacting bladder and bowel function in an Australian community cohort. Disabil Rehabil. 2009;31:1567–1576.
    1. Brichetto G, Uccelli MM, Mancardi GL, Solaro C. Symptomatic medication use in multiple sclerosis. Mult Scler. 2003;9:458–461.
    1. Griffith G. Importance of continence advice for people with multiple sclerosis. Br J Nurs. 2002;11:1363–1371.
    1. Kirkland VL, Palmer MH, Fitzgerald ST. Incontinence in a manufacturing setting: women’s perceptions and responses. Public Health Nurs. 2001;18:312–317.
    1. Goldstein M, Hawthorne ME, Engeberg S, et al. Urinary incontinence: why people do not seek help. J Gerontol Nurs. 1992;18:15–20.
    1. Fischer JS, LaRocca NG, Miller DM, et al. Recent developments in the assessment of quality of life in multiple sclerosis (MS) Mult Scler. 1999;5:251–259.
    1. Dilorenzo T, Halper J, Picone MA. Reliability and validity of the multiple sclerosis quality of life inventory in older individuals. Disabil Rehabil. 2003;25:891–897.
    1. Bates D, Burks J, Globe D, et al. Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool. BMC Neurol. 2013;13:1–9. . doi: .
    1. Hess R, Santucci A, McTigue K, et al. Patient difficulty using tablet computers to screen in primary care. J Gen Intern Med. 2008;23:476–480.
    1. Bliven BD, Kaufman SE, Spertus JA. Electronic collection of health-related quality of life data: validity, time benefits, and patient preference. Qual Life Res. 2001;10:15–22.
    1. Denis F, Viger L, Charron A, et al. Detection of lung cancer relapse using self-reported symptoms transmitted via an internet web-application: pilot study of the sentinel follow-up. Support Care Cancer. 2014;22:1467–1473.
    1. Hanly JG, Omisade A, Su L, et al. Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological tests. Arthritis Rheum. 2010;62:1478–1486.
    1. Ruet A, Deloire MSA, Charré-Morin J, et al. A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis. Mult Scler. 2013;19:1665–1672.
    1. Akbar N, Honarmand K, Kou N, et al. Validity of an Internet version of the Multiple Sclerosis Neuropsychological Questionnaire. Mult Scler. 2010;16:1500–1506.
    1. Rudick RA, Miller D, Bethoux F, et al. The Multiple Sclerosis Performance Test (MSPT): an iPad-based disability assessment tool. J Vis Exp. 2014;88:1–13. . doi: .
    1. Papathanasiou A, Messinis L, Georgiou VL, Papathanasopoulos P. Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery. ISRN Neurol. 2014;2014:1–7. . doi: .
    1. Ford DV, Jones KH, Middleton RM, et al. The feasibility of collecting information from people with multiple sclerosis for the UK MS register via a web portal: characterising a cohort of people with MS. BMC Med Inform Decis Mak. 2012;12:1–8. . doi: .
    1. Fritz F, Ständer S, Breil B, et al. CIS-based registration of quality of life in a single source approach. BMC Med Inform Decis Mak. 2011;11:1–9. . doi: .
    1. Fritz F, Balhorn S, Riek M, et al. Qualitative and quantitative evaluation of EHR-integrated mobile patient questionnaires regarding usability and cost-efficiency. Int J Med Inform. 2012;81:303–313.
    1. Shaw C, Tansey R, Jackson C, et al. Barriers to help seeking in people with urinary symptoms. Fam Pract. 2001;18:48–52.
    1. Fitzgerald ST, Palmer MH, Berry SJ, Hart K. Urinary incontinence: impact on working women. AAOHN J. 2000;48:112–118.
    1. Krupp LB, Rizvi SA. Symptomatic therapy for underrecognized manifestations of multiple sclerosis. Neurology. 2002;58(suppl 4):S32–S39.
    1. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться